Table 1 Cohorts of obese adolescents with (IR+) and without (IR−) IR
Cohort 1 | Cohort 2 | Whole tested population | ||||
|---|---|---|---|---|---|---|
IR+ | IR− | IR+ | IR− | IR+ | IR− | |
Gender, n | ||||||
Males | 48 | 50 | 39 | 38 | 87 | 88 |
Females | 50 | 50 | 40 | 40 | 90 | 90 |
Age (years) | 13.8 (13.3–14.3) | 12.6 (12.0–13.1) | 13.9 (13.3–14.5) | 13.8 (13.2–14.4) | 13.8 (13.5–14.2) | 13.1 (12.7–13.5) |
BMI-SDS (kg m−2) | 3.03 (2.93–3.14) | 2.85 (2.76–2.94) | 2.88 (2.77–2.98) | 2.82 (2.72–2.92) | 2.96 (2.89–3.04) | 2.84 (2.77–2.90) |
HbA1c (%) | 5.20 (5.15–5.26) | 5.19 (5.13–5.24) | 5.15 (5.10–5.21) | 5.13 (5.08–5.19) | 5.18 (5.14–5.22) | 5.16 (5.12–5.2) |
HOMA-IR | 4.62 (4.22–5.02) | 1.85 (1.70–1.99) | 4.57 (4.08–5.06 | 1.81 (1.63–1.98) | 4.60 (4.29–4.91) | 1.83 (1.72–1.94) |
WBISI | 2.23 (2.11–2.36) | 5.58 (5.08–6.08) | 2.28 (2.15–2.42) | 5.93 (5.35–6.51) | 2.26 (2.16–2.35) | 5.73 (5.36–6.11) |
Systolic blood pressure (mm Hg) | 128.8 (126.2–131.3) | 123.5 (121.0–126.1) | 126.5 (123.8–129.2) | 124.6 (122.2–127.1) | 127.7 (125.9–129.6) | 124.0 (122.2–125.8) |
Diastolic blood pressure (mm Hg) | 68.8 (66.6–71.0) | 64.8 (63.0–66.5) | 65.7 (63.7–67.7) | 64.5 (62.8–66.3) | 67.4 (65.9–68.9) | 64.7 (63.4–65.9) |
Total cholesterol (mmol L−1) | 4.11 (3.98–4.25) | 4.24 (4.09–4.40) | 4.26 (4.06–4.46) | 3.99 (3.83–4.15) | 4.18 (4.06–4.30) | 4.13 (4.02–4.24) |
LDL (mmol L−1) | 2.49 (2.37–2.60) | 2.57 (2.44–2.71) | 2.62 (2.45–2.80) | 2.38 (2.24–2.52) | 2.55 (2.45–2.65) | 2.49 (2.39–2.59) |
HDL (mmol L−1) | 1.11 (1.06–1.16) | 1.20 (1.15–1.26) | 1.10 (1.04–1.15) | 1.17 (1.11–1.22) | 1.11 (1.07–1.14) | 1.19 (1.15–1.23) |
Triglycerides (mmol L−1) | 1.39 (1.26–1.53) | 1.07 (0.97–1.18) | 1.31 (1.18–1.44) | 1.04 (0.94–1.14) | 1.36 (1.26–1.45) | 1.06 (0.99–1.13) |